Skip to main content
Signal8

Poulton Stuart

SEC insider (Form 3/4/5 filer). CIK 0001942597. EVP, Chief Development Officer at Karyopharm Therapeutics Inc. (KPTI). 14 reported Form 4/5 transactions since Sep 2024; latest on Jul 28, 2026. Located in NEWTON, MA.

Companies Poulton Stuart has filed insider reports for

  • Karyopharm Therapeutics Inc. (KPTI): Officer, EVP, Chief Development Officer
Poulton Stuart profile photo

Poulton Stuart

CIK: 0001942597

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)8 (57.1%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Karyopharm Therapeutics Inc. logo
KPTI

Karyopharm Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (14 total)

  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Jul 28, 2026
    Sale
    Direct
    189 shares at avg. $7.10$1K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    May 14, 2026
    Sale
    Direct
    403 shares at avg. $9.50$4K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    May 13, 2026
    Award
    Direct
    896 shares-
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Mar 2, 2026
    Sale
    Direct
    5.1K shares at avg. $9.41$48K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Feb 17, 2026
    Sale
    Direct
    378 shares at avg. $8.63$3K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Jan 31, 2026
    Award
    Direct
    32.4K shares-
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Oct 15, 2025
    Award
    Direct
    39.7K shares-
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Sep 15, 2025
    Sale
    Direct
    401 shares at avg. $6.43$3K
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Sep 12, 2025
    Award
    Direct
    888 shares-
  • Karyopharm Therapeutics Inc. logo
    KPTI

    Karyopharm Therapeutics Inc.

    Jul 29, 2025
    Sale
    Direct
    191 shares at avg. $4.37$834.67

1-10 of 14